If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPHC.L Regulatory News (PHC)

  • There is currently no data for PHC

Board Appointments

18 Jan 2023 07:00

RNS Number : 0474N
Plant Health Care PLC
18 January 2023
 

18 January 2023

 

PLANT HEALTH CARE plc 

("Plant Health Care" or the "Company")

 

Board Appointments

 

Plant Health Care® (AIM: PHC.L), a leading provider of novel peptides for plant protection to global agriculture markets, is pleased to announce the appointments of Kate Coppinger and James Ede-Golightly as Non-Executive Directors.

Kate Coppinger is an experienced Non-Executive Director with an extensive background in investment banking and transaction execution. Having started her career as a research analyst at CIBC World Markets, she joined Harrison Lovegrove in 2000 and continued in her role, which focused on M&A transactions, within Standard Chartered Bank until 2020 following its acquisition of Harrison Lovegrove in 2007.

James Ede-Golightly has over twenty years of experience as a professional investor and director of growth companies. His current roles include Executive Chairman of Oxehealth and Non-Executive Director of Silence Therapeutics Plc. He co-founded Ora Capital Partners in 2006 having been an analyst at Commerzbank AG and Merrill Lynch Investment Managers. James previously served as a Non-Executive Director of Plant Health Care, between June 2013 and November 2016.

 

Chris Richards, Non-Executive Chairman of Plant Health Care, commented:

"We are delighted Kate has joined the Board. Her background in M&A and regulated industries will be an asset in terms of the Company's future product development and geographic expansion.

"In addition, it is great to welcome James back to the Company to help us capture the growth opportunities that we have identified.

"Maintaining the right balance of skills and experience on the Board is one of the keys to our continued progress. These appointments strengthen the Company and we look forward to working with Kate and James as we deliver our exciting growth proposition."

 

For further information, please contact:

 

Plant Health Care plc

Jeffrey Tweedy, Chief Executive Officer

Tel: +1 919 926 1600

Jeffrey Hovey, Chief Financial Officer

 

Cenkos Securities plc - Nomad & Broker

Neil McDonald / Pete Lynch

 

 

Tel: + (0) 131 220 9771

 

SEC Newgate (Financial Communications)

Tel:+44 (0)7540 10666

Robin Tozer / George Esmond

Email: phc@secnewgate.co.uk

 

 

The following information regarding the appointment of Kate Coppinger and James Ede-Golightly is required to be disclosed under Schedule 2(g) of the AIM Rules for Companies:

Full Name:

Katherine Jane Coppinger

Age:

52

Shareholding in the Company:

-

 Current Directorship / Partnerships:

 iGas Energy plc

The Barnes Fund Trustee Limited

Serica Energy plc

Previous Directorship / Partnerships:

-

 

Full Name:

James Lawrence Ede-Golightly

Age:

43

Shareholding in the Company:

625,608 ordinary shares

Current Directorship / Partnerships:

Dunheved Limited

East Balkan Properties Plc

Guernsey Chamber of Commerce

Ora Global Ltd

Oxeco Limited

Oxehealth Limited

Sarossa Plc

Serendipity Capital Limited

Silent Therapeutics Plc

Previous Directorship / Partnerships:

DeepMatter Group Plc

Fermain Capital Limited

Gulfsands Petroleum Plc

Ora Limited

Oxford Advanced Surfaces Ltd

Quoram Limited (previously Quoram Plc)

 

There are no further disclosures to be made under Schedule 2(g) of the AIM Rules for Companies.

About Plant Health Care plc

Plant Health Care offers products to improve the health, vigour and yield of major field crops such as corn, soybeans, potatoes and rice, as well as specialty crops such as fruits and vegetables. We operate globally through subsidiaries, distributors and supply agreements with major industry partners. Our innovative, patent-protected biological products help growers to protect their crops from stress and diseases, and to produce higher quality fruit and vegetables, with a favourable environmental profile.

 

Find out more at www.planthealthcare.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOADBGDBDXBDGXR
Date   Source Headline
28th Jun 202312:29 pmRNSHolding(s) in Company
27th Jun 20234:08 pmRNSHolding(s) in Company
27th Jun 20231:08 pmRNSDirector Shareholding
23rd Jun 20237:00 amRNSResult of Fundraising
22nd Jun 20234:35 pmRNSFundraising to raise up to US$3.6 million
14th Jun 20237:00 amRNSWilbur Ellis Agreement
13th Jun 20231:43 pmRNSResult of AGM
30th May 20237:00 amRNSHolding(s) in Company
24th May 20231:12 pmRNSHolding(s) in Company
19th May 20235:55 pmRNSPublication of Annual Report and Notice of AGM
18th May 20237:00 amRNSResult of Consultation
9th May 20237:00 amRNSPHC68949 granted first stage of approval in Brazil
2nd May 20237:10 amRNSResults for the year ended 31 December 2022
12th Apr 20232:33 pmRNSNotice of Results
5th Apr 20235:29 pmRNSHolding(s) in Company
8th Mar 20232:45 pmRNSExercise of Options
2nd Mar 20237:00 amRNSBiofungicide PHC279 Approved by US EPA
1st Mar 20237:00 amRNSDirector/PDMR Shareholding
6th Feb 20237:00 amRNSTrading Statement
30th Jan 202312:08 pmRNSSignificant Shareholder
18th Jan 20237:00 amRNSBoard Appointments
12th Jan 20237:00 amRNSNovozymes Distribution Agreement
9th Jan 20237:00 amRNSInvestor Presentation
22nd Dec 20227:00 amRNSNew Products Submitted for Regulatory Approval
28th Oct 20227:00 amRNSRegistration of Harpin in France
28th Oct 20227:00 amRNSNew distribution agreement with EDAF
27th Oct 20227:00 amRNSTrading Update
14th Oct 20225:11 pmRNSDirector/PDMR Shareholding
14th Oct 202210:39 amRNSDirector / PDMR Shareholding
26th Sep 20227:00 amRNSInterim Results
22nd Aug 20227:00 amRNSTrials agreement signed with Agrii UK
12th Aug 20227:00 amRNSGrant of Options
10th Aug 20225:04 pmRNSDirector/PDMR Shareholding
21st Jul 20222:41 pmRNSHolding(s) in Company
18th Jul 20227:02 amRNSInvestor Presentation
18th Jul 20227:00 amRNSPost-Close Trading Update
22nd Jun 202212:37 pmRNSResult of AGM
21st Jun 20227:00 amRNSCompletion of Nominated Adviser due diligence
20th Jun 20227:00 amRNSLong-term Harpin Production and Supply Agreement
6th Jun 20228:00 amRNSHolding(s) in Company
6th Jun 20228:00 amRNSHolding(s) in Company
1st Jun 20222:31 pmRNSDirector/PDMR Shareholding
25th May 20225:23 pmRNSHolding(s) in Company
23rd May 20227:30 amRNSAnnual Report & Accounts and Notice of AGM
23rd May 20227:00 amRNSNew distribution agreement with Nutrien
16th May 20227:00 amRNSHolding(s) in Company
12th May 20227:15 amRNSCEO appointment and Board changes
12th May 20227:00 amRNSResults for the year ended 31 December 2021
28th Apr 20227:00 amRNSChange of Adviser
21st Apr 20222:27 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.